The role of MRI in the prognosis of Wernicke’s encephalopathy
dc.contributor.author | Kitaguchi, Tomoaki | |
dc.contributor.author | Ota, Yoshiaki | |
dc.contributor.author | Liao, Eric | |
dc.contributor.author | Moritani, Toshio | |
dc.contributor.author | Shah, Gaurang | |
dc.contributor.author | Yamada, Kei | |
dc.contributor.author | Srinivasan, Ashok | |
dc.date.accessioned | 2023-12-04T20:24:23Z | |
dc.date.available | 2024-12-04 15:24:22 | en |
dc.date.available | 2023-12-04T20:24:23Z | |
dc.date.issued | 2023-11 | |
dc.identifier.citation | Kitaguchi, Tomoaki; Ota, Yoshiaki; Liao, Eric; Moritani, Toshio; Shah, Gaurang; Yamada, Kei; Srinivasan, Ashok (2023). "The role of MRI in the prognosis of Wernicke’s encephalopathy." Journal of Neuroimaging 33(6): 917-925. | |
dc.identifier.issn | 1051-2284 | |
dc.identifier.issn | 1552-6569 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/191572 | |
dc.description.abstract | Background and PurposeWernicke’s encephalopathy (WE) is a severe acute disorder related to thiamine deficiency. This study was aimed at revealing the relationship between clinical and imaging findings and WE recovery.MethodsWe retrospectively reviewed 34 cases of WE diagnosed between 2003 and 2020 (median age: 57 years, 14 females) at two academic institutions. WE cases were divided into two groups with symptomatic recovery within 4 weeks (group 1) or later (group 2). The lesion sites were divided into typical and atypical sites (total sites defined as when either typical or atypical sites were involved). Clinical and MRI features were compared between them as appropriate.ResultsWE patients were divided into group 1 (19 cases, median age: 57 years, 10 females) and group 2 (15 cases, median age: 57 years, four females). Regarding clinical features, only cerebellar ataxia was more often observed in group 1 than in group 2. Regarding MRI features, signal abnormality on T2-weighted image (WI)/fluid-attenuated inversion recovery (FLAIR) was more often observed in atypical sites between groups 1 and 2 (1/19 vs. 7/15; p = .01). There were significant differences between groups 1 and 2 regarding the presence of both vasogenic edema and cytotoxic edema in total sites (4/11 vs. 11/15, p = .005; 1/19 vs. 6/15, p = .03), with a significant difference in the presence of vasogenic edema in typical sites (4/19 vs. 10/15, p = .01).ConclusionThe early recovered group showed a lower incidence of T2WI/FLAIR abnormality in atypical sites and diffusion signal abnormality in total or typical sites with a lower incidence of cerebellar ataxia. | |
dc.publisher | North-Holland Publishing Company | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | Wernicke’s encephalopathy | |
dc.subject.other | DWI | |
dc.subject.other | prognosis | |
dc.title | The role of MRI in the prognosis of Wernicke’s encephalopathy | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Neurosciences | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/191572/1/jon13143_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/191572/2/jon13143.pdf | |
dc.identifier.doi | 10.1111/jon.13143 | |
dc.identifier.source | Journal of Neuroimaging | |
dc.identifier.citedreference | Galvin R, Bråthen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010; 17: 1408 – 18. | |
dc.identifier.citedreference | Zuccoli G, Santa Cruz D, Bertolini M, et al. MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol. 2009; 30: 171 – 6. | |
dc.identifier.citedreference | Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J. 2014; 44: 911 – 5. | |
dc.identifier.citedreference | Lough ME. Wernicke’s encephalopathy: expanding the diagnostic toolbox. Neuropsychol Rev. 2012; 22: 181 – 94. | |
dc.identifier.citedreference | Sechi G, Serra A. Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007; 6: 442 – 55. | |
dc.identifier.citedreference | Ghez C. Vestibular paresis: a clinical feature of Wernicke’s disease. J Neurol Neurosurg Psychiatry. 1969; 32: 134 – 9. | |
dc.identifier.citedreference | Ha ND, Weon YC, Jang JC, et al. Spectrum of MR imaging findings in Wernicke encephalopathy: are atypical areas of involvement only present in nonalcoholic patients? AJNR Am J Neuroradiol. 2012; 33: 1398 – 402. | |
dc.identifier.citedreference | Sechi GP, Serra A. Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007; 6: 442 – 55. | |
dc.identifier.citedreference | Victor M. The Wernicke-Korsakoff syndrome. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology: volume 28, part II. Amsterdam: North-Holland Publishing Company; 1976: 243 – 70. | |
dc.identifier.citedreference | Jung YC, Chanraud S, Sullivan EV. Neuroimaging of Wernicke’s encephalopathy and Korsakoff’s syndrome. Neuropsychol Rev. 2012; 22: 170 – 80. | |
dc.identifier.citedreference | Zuccoli G, Pipitone N. Neuroimaging findings in acute Wernicke’s encephalopathy: review of the literature. AJR Am J Roentgenol. 2009; 192: 501 – 8. | |
dc.identifier.citedreference | Manzo G, De Gennaro A, Cozzolino A, et al. MR imaging findings in alcoholic and nonalcoholic acute Wernicke’s encephalopathy: a review. Biomed Res Int. 2014; 2014: 503596. | |
dc.identifier.citedreference | Chung SP, Kim SW, Yoo IS, et al. Magnetic resonance imaging as a diagnostic adjunct to Wernicke’s encephalopathy in the ED. Am J Emerg Med. 2003; 21: 497 – 502. | |
dc.identifier.citedreference | Antunez E, Estruch R, Cardenal C, et al. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke’s encephalopathy. AJR Am J Roentgenol. 1998; 171: 1131 – 7. | |
dc.identifier.citedreference | Torvik A, Lindboe CF, Rodge S. Brain lesions in alcoholics: a neuropathological study with clinical correlations. J Neurol Sci. 1982; 56: 233 – 48. | |
dc.identifier.citedreference | Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry. 1986; 49: 341 – 5. | |
dc.identifier.citedreference | Ota Y, Capizzano AA, Moritani T, et al. Comprehensive review of Wernicke encephalopathy: pathophysiology, clinical symptoms and imaging findings. Jpn J Radiol. 2020; 38: 809 – 20. | |
dc.identifier.citedreference | Ogershok PR, Rahman A, Nestor S, et al. Wernicke encephalopathy in nonalcoholic patients. Am J Med Sci. 2002; 323: 107 – 11. | |
dc.identifier.citedreference | Chandrakumar A, Bhardwaj A, Jong GW. Review of thiamine deficiency disorders: Wernicke encephalopathy and Korsakoff psychosis. J Basic Clin Physiol Pharmacol. 2018; 30: 153 – 62. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.